Corrosions classified according to extent of body surface involved

ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — T32 Cause of death: ICD-10 — T32 2 out of 7 registries used, show all original rules.	45
4. Check minimum number of events None	45
5. Include endpoints None	45
6. Filter based on genotype QC (FinnGen only)	45

Control definitions (FinnGen only)

Control exclude: CD2_BENIGN_FEMALE_GEN_OTH

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF4
Parent code in ICD-10: T29|T3[0-2]
Name in latin: Corrosiones secundum summam superficiei corporis corrosam classificatae

NAME	ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED
CONTROL_EXCLUDE	CD2_BENIGN_FEMALE_GEN_OTH
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	T32
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	T32
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Corrosions classified according to extent of body surface involved based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	45	26	19
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	46.83	49.11	43.71

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022217) INR in Platelet poor plasma by Coagulation assay

3.66

2.22

11.5

10.3

—

1.28

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

4.44

2.11

1.3

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.71

1.88

1.4

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.82

1.69

1.5

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.72

1.63

1.5

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2.88

1.59

1.4

2.7

13.56

15.33

nmol/l

—

(3023368) Bacteria identified in Blood by Culture

2.15

1.50

2.9

4.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

3.17

1.40

1.0

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

108

1.92

1.19

1.9

3.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

0.00

0.99

0.0

5.5

—

0.55

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

269

1.85

0.98

5.2

4.0

15.20

14.74

pmol/l

0.47

251

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2.23

0.93

3.0

5.2

—

(36304419) Bacteria [Presence] in Urine

1.77

0.83

1.5

2.7

—

(40758558) Short blood count panel - Blood

1.77

0.83

5.2

7.4

—

(3025941) Bacteria identified in Stool by Culture

0.00

0.80

0.0

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

356

2.11

0.77

14.4

34.89

21.12

mg/l

1.12

272

(40761536) Microorganisms panel - Urine sediment

2.21

0.77

1.6

3.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

1.94

0.77

1.9

1.4

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.12

0.75

1.6

2.0

—

(3021601) Nitrite [Presence] in Urine by Test strip

160

1.59

0.72

5.6

0.00

estimate

—

(40768797) Stomach Pathology biopsy report

1.74

0.70

1.4

1.3

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.74

0.70

1.3

1.6

—

(3042936) Bacteria identified in Isolate by Culture

1.70

0.69

2.3

2.6

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

330

1.68

0.67

5.2

4.6

1.82

1.83

mu/l

0.01

305

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1.75

0.63

2.2

2.4

4.88

4.66

pmol/l

—

(3037467) Urinalysis macro (dipstick) panel - Urine

233

1.53

0.62

5.0

4.3

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

155

1.52

0.62

5.1

7.1

1.21

1.22

mmol/l

0.25

134

(3008898) HLA-B27 [Presence]

0.00

0.61

0.0

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1.82

0.60

7.0

5.5

—

(3003694) ABO and Rh group [Type] in Blood

0.55

0.60

2.0

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

126

1.42

0.43

4.9

4.1

—

(3009542) Hematocrit [Volume Fraction] of Blood

328

1.49

0.42

15.4

13.1

38.77

40.84

0.52

255

(40761511) CBC panel - Blood by Automated count

374

1.62

0.40

17.8

12.3

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1.44

0.39

1.4

1.6

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

147

1.37

0.39

4.2

5.6

1.20

1.22

mmol/l

0.59

134

(3019225) pH of Specimen

1.49

0.37

3.0

5.4

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

342

1.46

0.34

4.4

4.2

5.88

5.74

mmol/l

0.29

314

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

335

1.37

0.32

8.7

13.9

89.48

83.72

ml/min/173m2

0.86

272

(3013707) Erythrocyte sedimentation rate by Westergren method

261

1.31

0.30

2.7

4.7

9.33

10.35

mm/h

0.21

245

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

133

1.32

0.30

1.5

1.9

95.29

100.90

pmol/l

—

(3029937) Albumin [Presence] in Urine by Test strip

1.37

0.29

4.5

3.8

0.00

estimate

—

(3009261) Glucose [Presence] in Urine by Test strip

164

1.27

0.26

4.4

3.9

0.00

estimate

—

(40768804) Tissue Pathology biopsy report

154

0.78

0.24

1.6

1.9

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.00

0.21

0.0

4.1

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.4

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

15.05

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

4.8

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

0.00

0.21

0.0

1.4

—

169.70

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

11.06

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

0.00

0.21

0.0

1.5

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

0.00

0.21

0.0

4.5

—

(3037121) Protein [Mass/volume] in Urine

0.00

0.21

0.0

2.8

—

0.29

—

(3049717) Cytology report of Urine Cyto stain

0.00

0.21

0.0

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

0.00

0.21

0.0

1.7

—

227.60

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.21

0.0

2.3

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

0.00

0.21

0.0

1.3

—

102.38

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

1.24

0.18

5.1

3.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

0.75

0.17

1.3

1.8

—

(3019150) Specific gravity of Urine by Refractometry

0.78

0.17

6.8

4.4

—

1.02

—

(40760892) CBC W Ordered Manual Differential panel - Blood

0.78

0.17

1.7

6.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

0.82

0.15

2.4

3.1

343.00

349.34

umol/l

—

(3035350) Ketones [Presence] in Urine by Test strip

162

1.19

0.15

4.5

3.9

0.00

estimate

—

(3015736) pH of Urine

123

1.20

0.15

5.3

3.7

—

(3013512) EKG study

104

1.21

0.14

3.0

3.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

154

1.17

0.12

3.5

4.3

—

(3044889) 12 lead EKG panel

235

1.14

0.10

3.7

3.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

1.18

0.10

1.8

—

(1761868) Lipid panel - Serum or Plasma

136

1.15

0.10

3.2

2.5

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1.05

0.09

1.8

2.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1.13

0.08

2.0

2.8

—

(3041096) Erythrocytes [Presence] in Urine by Automated

1.15

0.07

3.5

3.7

—

(3026008) Bacteria identified in Urine by Culture

1.13

0.04

4.6

3.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

341

1.12

0.04

3.6

1.37

1.31

mmol/l

0.18

309

(3032080) INR in Blood by Coagulation assay

131

1.10

0.04

6.5

7.4

0.98

1.14

inr

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

358

0.90

0.03

4.0

4.1

1.39

1.47

mmol/l

0.53

330

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

358

0.90

0.03

4.0

4.1

4.82

4.70

mmol/l

0.29

330

(42870588) Differential panel, method unspecified - Blood

113

0.96

0.00

6.0

5.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

325

1.06

0.00

4.0

4.9

38.53

38.74

mmol/mol

0.08

305

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

246

1.04

0.00

3.2

3.4

—

(3044640) Blood type and Crossmatch panel - Blood

108

1.02

0.00

1.9

2.6

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

1509.40

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

0.0

2.7

—

110.00

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

0.00

0.0

1.2

—

(3008037) Lactate [Moles/volume] in Venous blood

0.00

0.0

3.4

—

1.28

—

(3023420) DNA double strand Ab [Units/volume] in Serum

0.00

0.0

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.0

1.3

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

0.00

0.0

2.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

0.00

0.0

3.2

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

0.00

0.0

6.6

—

0.62

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.7

—

0.00

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

0.00

0.0

4.2

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

380

1.00

0.00

16.4

16.0

73.89

76.74

umol/l

0.42

380

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.0

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3023410) Appearance of Cerebral spinal fluid

0.00

0.0

1.0

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

260

1.00

0.00

5.5

3.3

61.43

44.76

u/l

0.37

252

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

5.88

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

0.0

2.7

—

(3032773) Endomysium IgG Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.0

1.3

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

0.00

0.0

3.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.90

0.00

1.4

1.3

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.6

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

0.0

1.0

—

(1616796) Gas panel - Central venous blood

0.00

0.0

2.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.3

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

0.0

1.1

—

(3044927) Protein electrophoresis panel - Urine

0.00

0.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.0

1.3

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.0

1.3

—

(3037756) Immunofixation for Serum or Plasma

0.00

0.0

1.0

—

(4268621)

0.00

0.0

1.8

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.0

1.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.0

1.0

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.6

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3052851) Hemolysis interference index of Serum or Plasma

0.00

0.0

2.7

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.1

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

0.97

0.00

1.3

1.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

0.85

0.00

1.0

1.6

—

(3004616) Nuclear Ab [Presence] in Serum

0.00

0.0

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.0

1.6

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

0.0

2.7

—

4.04

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

5.6

—

145.71

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

0.0

1.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.5

—

11.18

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

0.0

1.1

—

(4027681)

0.00

0.0

1.0

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

0.0

3.4

—

6.75

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

0.00

0.0

3.0

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

0.00

0.0

1.3

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

0.00

0.0

2.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

2.11

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

0.00

0.0

2.2

—

29.08

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

0.00

0.0

3.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

2.7

—

0.00

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.0

1.0

—

0.99

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED – Corrosions classified according to extent of body surface involved

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Corrosions classified according to extent of body surface involved

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Corrosions classified according to extent of body surface involved (ST19_CORROSIO_CLASSIFIED_ACCOR_EXTENT_BODY_SURFA_INVOLVED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Relationships between endpoints